Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.26 - $0.47 $11,312 - $20,448
-43,508 Reduced 99.18%
360 $0
Q1 2023

May 12, 2023

BUY
$0.3 - $0.6 $419 - $838
1,398 Added 3.29%
43,868 $16,000
Q4 2022

Feb 13, 2023

BUY
$0.21 - $18.5 $2,756 - $242,849
13,127 Added 44.74%
42,470 $10,000
Q3 2022

Nov 14, 2022

SELL
$0.6 - $17.5 $8,760 - $255,517
-14,601 Reduced 33.23%
29,343 $16,000
Q2 2022

Aug 12, 2022

SELL
$1.61 - $4.68 $1.26 Million - $3.65 Million
-780,039 Reduced 94.67%
43,944 $72,000
Q1 2022

May 12, 2022

SELL
$1.79 - $4.65 $39,428 - $102,425
-22,027 Reduced 2.6%
823,983 $3.47 Million
Q4 2021

Feb 10, 2022

BUY
$4.11 - $15.13 $137,052 - $504,524
33,346 Added 4.1%
846,010 $3.9 Million
Q3 2021

Nov 09, 2021

BUY
$10.32 - $16.9 $5.04 Million - $8.25 Million
488,140 Added 150.42%
812,664 $12.3 Million
Q2 2021

Aug 11, 2021

BUY
$14.98 - $23.89 $4.86 Million - $7.75 Million
324,524 New
324,524 $5.3 Million

About NexImmune, Inc.


  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $6.04M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.